0Suppliers
12Customers
1Debt Items
20Related Chains

Source-Backed Evidence Depth

Apollomics, Inc. (APLM) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

14Total relationships
1Distinct source URLs
2High confidence
0.674Average confidence
2026-09-14Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Apollomics, Inc. Suppliers

No suppliers on recordApollomics, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Apollomics, Inc. Customers

TickerNameConfidenceEvidence
JNJ Johnson & Johnson 72% y’s material breach (subject to specified conditions) or by CTTQ if the licensed patents (i) have been or are evidenced to be invalidated or (ii) have infringed or are evidenced to infringe other thi…
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from APLM graph: y’s material breach (subject to specified conditions) or by CTTQ if the licensed patents (i) have been or are evidence…
AUSTRALIA-PTY-LTD AUSTRALIA-PTY-LTD 62% ese laws for, among other things, allegedly inflating drug prices they report to pricing services, which in turn were used by the government to set Medicare and Medicaid 80 Table of Contents reimburs…
BIOTECHNOLOGY-CO-LTD BIOTECHNOLOGY-CO-LTD 62% minate the Pearl Sublicense Agreement by written notice for convenience. Either party may, subject to specified cure periods, terminate the Pearl Sublicense Agreement in the event of the other party’…
CB-THERAPEUTICS-INC CB-THERAPEUTICS-INC 62% y’s material breach (subject to specified conditions) or by CTTQ if the licensed patents (i) have been or are evidenced to be invalidated or (ii) have infringed or are evidenced to infringe other thi…
EDDING-GENOR-GROUP-HOLDINGS-LIMITED EDDING-GENOR-GROUP-HOLDINGS-LIMITED 62% Unless earlier terminated by either party due to the other party’s material breach (subject to specified conditions), the Genor Agreement remains effective until the later of (i) the full performance…
EDDING-GROUP-COMPANY-LIMITED EDDING-GROUP-COMPANY-LIMITED 62% Unless earlier terminated by either party due to the other party’s material breach (subject to specified conditions), the Genor Agreement remains effective until the later of (i) the full performance…
HUMAN-GENETIC-RESOURCES HUMAN-GENETIC-RESOURCES 62% s-border transfer of personal information and governing our data privacy and security practices. We routinely receive, collect, generate, store, process, transmit and maintain medical data treatment …
LAUNXP-BIOMEDICAL-CO-LTD LAUNXP-BIOMEDICAL-CO-LTD 62% y’s material breach (subject to specified conditions) or by CTTQ if the licensed patents (i) have been or are evidenced to be invalidated or (ii) have infringed or are evidenced to infringe other thi…
LAUNXP-INTERNATIONAL-CO-LTD LAUNXP-INTERNATIONAL-CO-LTD 62% fixed payments (including in-substance fixed payments) less any lease incentives receivable. The lease liability is subsequently measured by increasing the carrying amount to reflect interest on the …
MAXPRO-INVESTMENT-CO-LTD MAXPRO-INVESTMENT-CO-LTD 62% re, of the Company (the “PIPE Shares”), at a price per share of $3.9317 (the closing price on August 29, 2025), representing aggregate gross proceeds to the company of $4.1 million, prior to the paym…
NSCLC-THE-GROUP NSCLC-THE-GROUP 62% teen years following first commercial sale in the applicable region. LaunXP will be primarily responsible for the development of vebreltinib in combination with an EGFRi in the LaunXP territory (all …

Apollomics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
APLM-DEBT Debt stack $643,000 90% Market cache reports total debt of $643,000.

Apollomics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Apollomics, Inc..

Apollomics, Inc. Ownership

HolderNameConfidenceEvidence
APLM-OWNER-CITIGROUP-INC CITIGROUP INC 90% 13F overlay lists CITIGROUP INC as top holder; 4 tracked holders.

Apollomics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ABBV AbbVie Inc. 100.00 2
FDMT 4D Molecular Therapeutics, Inc. 100.00 2
CLGN CollPlant Biotechnologies Ltd. 100.00 2
ADGM Adagio Medical Holdings, Inc. 100.00 2
AURA Aura Biosciences, Inc. 100.00 2
ATON AlphaTON Capital Corp 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
BNR Burning Rock Biotech Limited 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
ACIU AC Immune SA 100.00 2
CSTE Caesarstone Ltd. 100.00 2
AORT Artivion, Inc. 100.00 2
SNNUF Smith & Nephew plc 100.00 2
ALC Alcon Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
ATRA Atara Biotherapeutics, Inc. 100.00 2
BLLN BillionToOne, Inc. 100.00 2
CRIS Curis, Inc. 100.00 2
🔐
APLM
Unlock APLM Supply Chain Data
Verified relationships include:
JNJJohnson & JohnsonCustomer72%
JNJJohnson & JohnsonCustomer72%
+10 more relationships locked
Subscribe — View plans →